financing

News

Daniel Nadler, co-founder and chief executive of OpenEvidence

Medical chatbot firm OpenEvidence raises $210m

OpenEvidence has raised $210m to expand the capabilities of its physician decision-making tool and launch a new service offering 'PhD-level' research.

News

New radiopharma Actithera emerges with $75.5m in financing

A new player in radioligand therapies, Actithera, has arrived on the scene with $75.5m in funding and lead FAP-targeted candidate for cancer.

News

Amid sector disruption, biotech must focus on 'fundamentals'...

The biotech industry in the US is facing a period of deep uncertainty under the Trump administration, but can ride out the storm, says EY.

News

rofessor John Atack and Professor Simon Ward, from Cardiff University’s Medicines Discovery Institute

Welsh biotech Draig emerges with $140m in financing

Draig Therapeutics emerged from the shadows this morning with $140m in funding and a quest to develop new therapies for neuropsychiatric diseases.

News

Caris swells its planned IPO, seeking $5.7bn valuation

AI-powered techbio firm Caris Life Sciences has raised the target price for its IPO, pointing to strong demand among investors.

News

SpliceBio chief executive Miquel Vila-Perelló

SpliceBio gathers $135m for eye disease gene therapies

Spain's SpliceBio has raised $135m in financing that will help it move a gene-editing therapy for Stargardt disease through clinical testing.

Medical chatbot firm OpenEvidence raises $210m

New radiopharma Actithera emerges with $75.5m in financing

Amid sector disruption, biotech must focus on 'fundamentals'...

Welsh biotech Draig emerges with $140m in financing

Caris swells its planned IPO, seeking $5.7bn valuation

SpliceBio gathers $135m for eye disease gene therapies

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

financing

Editor's Picks